Vistin Pharma ASA (OSL:VISTN)
Norway flag Norway · Delayed Price · Currency is NOK
21.30
+0.60 (2.90%)
At close: Feb 20, 2026

Vistin Pharma ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9459221,0511,033701859
Market Cap Growth
-9.36%-12.24%1.72%47.47%-18.47%11.06%
Enterprise Value
9299421,0531,034739809
Last Close Price
21.3020.8022.5520.6113.9717.14
PE Ratio
12.6412.3416.7522.66-34.56
Forward PE
-9.459.459.459.459.45
PS Ratio
2.092.042.452.362.303.08
PB Ratio
2.872.813.403.202.563.12
P/TBV Ratio
2.872.813.403.202.563.12
P/FCF Ratio
15.2314.8715.6714.21--
P/OCF Ratio
12.0011.729.7411.41-62.82
PEG Ratio
-1.721.721.721.721.72
EV/Sales Ratio
2.052.082.452.362.432.90
EV/EBITDA Ratio
8.088.2010.2012.19138.7118.91
EV/EBIT Ratio
10.0610.2012.3515.08-24.34
EV/FCF Ratio
14.9715.1815.7114.23--
Debt / Equity Ratio
0.010.010.00-0.180.01
Debt / EBITDA Ratio
0.010.010.01-7.950.03
Debt / FCF Ratio
0.020.020.02---
Net Debt / Equity Ratio
-0.04-0.04-0.04-0.080.18-0.12
Net Debt / EBITDA Ratio
-0.13-0.13-0.11-0.318.95-0.80
Net Debt / FCF Ratio
-0.24-0.24-0.17-0.36-0.641.88
Asset Turnover
1.101.101.091.080.820.85
Inventory Turnover
1.911.911.912.162.192.57
Quick Ratio
1.541.541.011.240.621.92
Current Ratio
2.582.582.242.431.353.36
Return on Equity (ROE)
23.42%23.42%19.85%15.29%-1.72%9.07%
Return on Assets (ROA)
14.00%14.00%13.53%10.58%-1.03%6.35%
Return on Invested Capital (ROIC)
22.30%23.54%22.33%17.30%-2.17%11.79%
Return on Capital Employed (ROCE)
25.60%25.60%26.60%20.50%-2.10%11.40%
Earnings Yield
7.91%8.11%5.97%4.41%-0.67%2.89%
FCF Yield
6.57%6.73%6.38%7.03%-10.68%-2.13%
Dividend Yield
7.04%7.21%5.54%4.85%5.37%4.38%
Payout Ratio
74.15%74.15%123.65%--89.17%
Total Shareholder Return
7.04%7.21%5.54%4.85%5.37%4.38%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.